Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
Date:2/10/2009

$51.7 million in the prior year.

The Company had total liquidity of $96.6 million, comprised of $58.4 million of cash and $38.2 million available under its revolving credit facility at December 31, 2008. The Company believes that it has sufficient liquidity to conduct its normal operations and fund its acquisition plan in 2009.

For 2009, the Company expects revenues to be between $750 million and $760 million which would result in growth of 6.7% to 8.1% compared to 2008. The Company also expects diluted EPS for 2009 to be in the range of $0.96 to $0.98, which would represent an 11.6% to 14.0% increase over 2008 pro forma diluted EPS and a 23.1% to 25.6% increase over 2008 GAAP diluted EPS.

"The Hanger team had an outstanding year in 2008 and I am extremely pleased with our performance in the fourth quarter, since it marks the twelfth consecutive quarter of meeting or exceeding First Call consensus estimates," commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group. Mr. Kirk added, "All elements of our company improved on last year's results to enable us to achieve 34.4% EPS growth in 2008. Hanger has a stable capital structure, ample liquidity to grow and handle our needs, as well as strong cash flow. I am proud of our team's accomplishments in 2008, and while we are concerned about the economy, we are excited about our prospects in 2009 as evidenced by our guidance which reflects strong growth in sales and EPS."

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 668 patient care centers in 45 states and the District of Columbia, with over 3,500 employees including 1,070 practitioners (as of December 31, 2008). Hanger is organized into four units. The two key operating units are patient
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
2. Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)
3. Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call
5. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
6. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
7. Hanger Orthopedic Group, Inc. Announces Second Quarter 2008 Earnings Release Conference Call
8. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Standard & Poors Rating Services
9. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
10. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
11. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... identified an important enzyme pathway that helps prevent new ... a condition that has been directly linked to cancer ... biochemistry, found that near the end of cell division, ... any breaks in DNA are fully repaired before the ... cells. This process helps safeguard against some of the ...
(Date:4/23/2014)... and accessible detection methods that can rapidly screen ... a single cell inside that population has been ... Lu. , In the Royal Society of Chemistry ... that he and his coworkers have developed a ... a protein ( Chem. Sci. , 2014, DOI: ...
(Date:4/23/2014)... April 21, 2014 Five for-profit and non-profit ... $1.25 million in Proof of Concept grants to ... into commercial products, the Life Sciences Discovery Fund ... Entrepreneur Mentoring Program grant to the Washington Biotechnology ... advisory network to train the next generation of ...
(Date:4/23/2014)... known as Ritalin, may prevent the depletion of self-control, ... a journal of the Association for Psychological Science. , ... or trying to focus attention on a boring textbook ... potential explanation for this difficulty: Exerting self-control for a ... self-control effectively on subsequent tasks. , "It is as ...
(Date:4/22/2014)... A recently FDA-approved device has been shown to ... much as 50 percent. When coupled with an innovative ... the device facilitated the complete elimination of seizures in ... the decade-long clinical trials. , That,s good news for ... the U.S. living with epilepsy whose seizures can,t be ...
Breaking Medicine News(10 mins):Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:ADHD drug may help preserve our self-control resources 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2
... can be significantly reduced by providing a simple intervention ... and alternatives of various imaging modalities, according to a ... Island, NY. , "Given the increased awareness ... medical imaging we hypothesized that a simple intervention of ...
... a strong relationship with their parents may start drinking at ... risk of developing alcohol problems, a new study suggests. , ... Journal of Studies on Alcohol and Drugs , underscore the ... , Past studies have suggested that the age at which ...
... A new study shows that the SAVI applicator, a ... partial breast irradiation, carries a low infection risk, a ... radiation oncologists and surgeons at the Moores UCSD Cancer ... indicates that other complications such as seromas, pockets ...
... (NYSE: VRX ) today announced that results ... clinical trial for taribavirin, a prodrug of ribavirin which ... C in conjunction with a pegylated interferon, was presented ... Liver (EASL) 44th Annual Meeting in Copenhagen, Denmark. ...
... at higher risk of aggressive recurrence only 8 months ... U.S. male military veterans exposed to the Agent Orange ... prostate cancer, a new study finds. , It included ... Of those, the 206 men who,d been exposed to ...
... NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ... supplements, today announced results for the fiscal second quarter and ... quarter ended March 31, 2009, net sales were $596 million ... March 31, 2008, an increase of $63 million or 12%. ...
Cached Medicine News:Health News:Good relationship with parents may prevent teen drinking problems 2Health News:Radiation device in the breast reduces complications for early stage breast cancer patients 2Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 2Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 3Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 4Health News:Agent Orange Exposure Tied to Prostate Cancer Return 2Health News:NBTY Reports Second Quarter Results 2Health News:NBTY Reports Second Quarter Results 3Health News:NBTY Reports Second Quarter Results 4Health News:NBTY Reports Second Quarter Results 5Health News:NBTY Reports Second Quarter Results 6Health News:NBTY Reports Second Quarter Results 7Health News:NBTY Reports Second Quarter Results 8Health News:NBTY Reports Second Quarter Results 9Health News:NBTY Reports Second Quarter Results 10Health News:NBTY Reports Second Quarter Results 11Health News:NBTY Reports Second Quarter Results 12Health News:NBTY Reports Second Quarter Results 13Health News:NBTY Reports Second Quarter Results 14Health News:NBTY Reports Second Quarter Results 15Health News:NBTY Reports Second Quarter Results 16Health News:NBTY Reports Second Quarter Results 17Health News:NBTY Reports Second Quarter Results 18Health News:NBTY Reports Second Quarter Results 19Health News:NBTY Reports Second Quarter Results 20
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC ... guide with accompanying instrumentation to place and insert the ... the soft tissue (e.g. ligament) repair or reconstruction as ... heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... Jan. 14, 2014 NineSigma , Inc., the ... Innovation Leadership Summit , May 14-16, 2014 at ... Cleveland Ohio . This is ... committed to breakthrough achievements through open innovation. Participants will ...
(Date:1/14/2014)... Md. , Jan. 14, 2014   Evidera , ... industry, announced that the Center for Drug Evaluation and ... its first draft qualification guidance document for a patient-reported ... Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Mass., May 10, 2011 In an on-going effort to ... Intelligence (CBI) announced today that the company will donate $5,200 ... conjunction with its annual Thanksgiving card issued to loyal conference ... card offering exclusive savings toward a future conference of choice. ...
... Reportlinker.com announces that a new market research ... Medical Imaging Reports Bundle ... Report Description The Medical Imaging ... at a 15% discount off the individual reports being purchased ...
Cached Medicine Technology:The Center for Business Intelligence Donates More than $5,000 to the Greater Boston Food Bank 2Reportlinker Adds Medical Imaging Reports Bundle 2Reportlinker Adds Medical Imaging Reports Bundle 3Reportlinker Adds Medical Imaging Reports Bundle 4Reportlinker Adds Medical Imaging Reports Bundle 5Reportlinker Adds Medical Imaging Reports Bundle 6Reportlinker Adds Medical Imaging Reports Bundle 7
... offers configurable user profiles and the improved ... entire testing and reporting process more efficient. ... stored in internal memory, and the X-Scribe ... a high-speed laser printer to significantly reduce ...
... to monitor, store and measure data during the ... can organize the amount of information detected during ... review and printout of an extremely flexible final ... a small portable ECG recorder (ECT 12 ...
... Automated Projector Chart w/ Remote/Controller. ... Refraction for Adults & Children. Multiple ... Included. Programmable feature allows you to ... access. Halogen Illumination with Long Life. ...
... the leader in beating heart bypass, comes ... Starfish NS device is the first leap ... acceptance of surgical revascularization.,The Starfish NS Heart ... Multi-Vessel Small Thoracotomy (MVST) procedure without CPB ...
Medicine Products: